Novacap, a French company that specializes in pharmaceutical synthesis and advanced specialties, is taking on new skills with the acquisition of a Massachusetts-based CDMO. More: Frances's Novacap scoops up U.S. CDMO Source: fierce
read moreMinakem, a CDMO subsidiary of Minafin, is in final qualifications to open its new closed-controlled environment high-containment production facility located in Belgium by late summer. More: CDMO Minakem’s new Belgium HPAPI facility in final qualifications ahead of opening Source: fierce
read moreItaly’s Recordati has long been weighing a sale, and things may now be getting serious. Private equity player CVC is in advanced talks to pick up a controlling stake—worth more than €3 billion—from the billionaire Recordati family, the Financial Times
read moreAbbVie has stored dozens of Humira patents in Bermuda, allowing it to lower its corporate tax rate, according to Reuters. How low? After U.S. tax reform, 9%. More: Why is AbbVie’s tax rate so low? Humira patents cached in Bermuda:
read moreAfter 5 years of declines in the number of new drug shortages in the U.S., they jumped to 39 last year from 26 in the two preceding years. And while that is a far cry from the peak of more
read moreHome secretary Sajid Javid has announced a review of medicinal cannabis in the UK, in response to growing pressure to allow use of cannabis oil to help control seizures in children with severe forms of epilepsy. More: UK announces review
read more© 1994 - 2026 B.M. Pharmaceuticals